THE HPV AND ANAL CANCER FOUNDATION (EIN 273217520) - Form 990 Financial Analysis & Trantor Score

🔒

Financial Vulnerability Assessment (Tuckman-Chang)

4 risk indicators measuring financial stability and operational resilience

Sign in with your work email to view Tuckman-Chang indicators

Financial Trends

Organization Details

Formation Year

2010

Legal Domicile

Principal Officer

JUSTINE X ALMADA

Phone

6465937739

Tax Period

2023-01-01 to 2023-12-31

THE HPV AND ANAL CANCER FOUNDATION, founded in 2010, is a small nonprofit in the Medical Research sector that reported $922K in total revenue in fiscal year 2023. Revenue surged 249% from the prior year, signaling strong growth momentum. The organization ran a surplus of $528K, a strong 57% operating margin.

Mission

TO EMPOWER ANAL CANCER PATIENTS AND ACCELERATE PREVENTION AND RESEARCH METHODS THAT ELIMINATE ANAL CANCER AND THE VIRUS THAT CAUSES THE MAJORITY OF CASES, HUMAN PAPILLOMAVIRUS (HPV).

🔒

Trantor Score

Financial Health Score (300–850) · Liquidity · Solvency · Sustainability · Efficiency

Sign in to view Trantor Score and financial metrics

Liquidity (40%) • Solvency (30%) • Sustainability (20%) • Efficiency (10%)

Financial Overview (2023)

Revenue Breakdown

Contributions & Grants $905,130

Program Service Revenue $13,205

Investment Income $3,994

Other Revenue $0

TOTAL REVENUE $922,329

Expense Breakdown

Grants Paid $29,178

Salaries & Benefits $154,974

Fundraising Expenses $37,378

Program Expenses $338,002

Other Expenses $209,698

TOTAL EXPENSES $393,850

Year-over-Year Comparison

	2023	2022	Change
Revenue	$922,329	$263,974	+2.5%
Expenses	$393,850	$396,446	0.0%
Net Income	$528,479	$-132,472	-5.0%

Key Indicators

✗ Grants to Organizations ✗ Grants to Individuals ✗ Lobbying ✗ Political Activity ✓ Foreign Activities ✗ Donor Advised Fund ✓ Schedule B Required

🔒

Financial Health Indicators

Comprehensive financial analysis: Altman Z-Score, liquidity, solvency, sustainability, efficiency, and growth metrics

Financial Distress Indicator

Liquidity & Cash Position

Sign in to view all financial metrics

Altman Z-Score • Liquidity Ratios • Solvency Analysis • Growth Indicators • Efficiency Metrics

Governance

Voting Members

Independent Members

Employees

Volunteers

233

Governance Policies

✓ Conflict of Interest Policy

✗ Whistleblower Policy

✗ Document Retention Policy

Special Practices & Reported Activities

✗ Operated a School

✗ Operated a Hospital

✗ Provided First Class Travel

⚠ Reported Conflict of Interest

✗ Reported Asset Diversion

✗ Excess Benefit Transaction

✗ Made Political Expenditures

✗ Engaged in Lobbying

✗ Operated Donor Advised Fund

✗ Maintained Art Collections

✗ Filed Form 720

Compensation of Officers, Directors & Key Employees

Total Officers

$59,550

Total Directors

$59,550

Key Employees

Highest Compensated

reported

Name	Title	Hours/Week	Role	Reportable Comp	Other Comp	Total
TRISTAN ALMADA	PRESIDENT	5.00	Officer Director	$0	$0	$0
CAMILLE ALMADA	VICE PRESIDENT & TREASURER	5.00	Officer Director	$0	$0	$0
CHRISTIAN LEVETT	DIRECTOR	1.00	Director	$0	$0	$0
JUSTINE X ALMADA	EXECUTIVE DIRECTOR	50.00	Officer Director	$59,550	$0	$59,550

Note: Compensation data is self-reported by the organization on their Form 990. "Reportable Comp" includes salary, bonuses, and other reportable compensation from the organization and related organizations. "Other Comp" includes benefits, deferred compensation, and non-taxable benefits.

Historical Data

Year	Revenue	Expenses	Assets	Net Income
2024	No data	No data	No data	No data
2023	$922,329	$393,850	$1,043,180	$528,479
2022	$263,974	$396,446	$510,364	$-132,472
2021	$299,284	$373,697	$595,078	$-74,413
2020	$264,444	$303,413	$651,230	$-38,969
2019	$640,984	$266,915	$646,994	$374,069
2018	$60,295	$234,547	$328,657	$-174,252

THE HPV AND ANAL CANCER FOUNDATION